Med Paper Cash Flow Statement

Financials in millions MAD. Fiscal year is January - December.

Millions MAD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Net Income	7.99	5.75	7.43	9.48	-
Depreciation & Amortization	1.13	-	-	-	-
Other Amortization	1.87	-	-	-	-
Loss (Gain) From Sale of Assets	-	-	-0.09	-	-
Other Operating Activities	2.53	5.8	5.39	4.63	-
Operating Cash Flow	13.52	11.55	12.72	14.12	-
Operating Cash Flow Growth	17.05%	-9.19%	-9.88%	-	-
Capital Expenditures	-1.4	-3.3	-7.78	-	-
Sale of Property, Plant & Equipment	-	-	0.09	-	-
Investing Cash Flow	-1.4	-3.3	-7.69	-	-
Long-Term Debt Issued	-	-	-	67	-
Long-Term Debt Repaid	-	-6.4	-	-34.57	-
Net Debt Issued (Repaid)	-	-6.4	-	32.43	-
Issuance of Common Stock	-	-	50.63	-	-
Other Financing Activities	-	-	-0.22	10.36	-
Financing Cash Flow	-	-6.4	50.41	42.79	-
Miscellaneous Cash Flow Adjustments	-2.33	-24.88	-73.39	-	-
Net Cash Flow	9.79	-23.03	-17.94	56.91	-
Free Cash Flow	12.13	8.25	4.94	14.12	-
Free Cash Flow Growth	47.00%	67.01%	-65.01%	-	-
Free Cash Flow Margin	11.49%	7.65%	3.67%	17.87%	-
Free Cash Flow Per Share	2.57	1.72	1.03	5.47	-
Levered Free Cash Flow	5.92	-24.29	-75.68	7.99	-
Unlevered Free Cash Flow	7.99	-21.36	-72.52	8.89	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.